CegedimFRA:C7E -2.32%81 Median PS Value is €32.14 as of Jun. 25, 2026, which is 100% below its 10-year median of 0.84. GuruFocus rates FRA:C7E with a GF Score™ of 81/100 and a GF Value™ of €12.57 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 264 Healthcare Providers & Services companies, Cegedim ranks better than 85.61% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Cegedim's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €44.293. Cegedim's 10-Year median PS Ratio is 0.7256. Therefore, the Median PS Value for today is €32.14.
As of today (2026-06-25), Cegedim's share price is €10.96. Cegedim's Median PS Value is €32.14. Therefore, Cegedim's Price to Median PS Value for today is 0.34.
The historical rank and industry rank for Cegedim's Median PS Value or its related term are showing as below:
FRA:C7E'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.34 Med: 0.84 Max: 1.6
Current: 0.34
During the past 13 years, the highest Price to Median PS Value of Cegedim was 1.60. The lowest was 0.34. And the median was 0.84.
FRA:C7E's Price-to-Median-PS-Value is ranked better than 85.61% of 264
companies
in the Healthcare Providers & Services industry
Industry Median: 0.7
vs FRA:C7E: 0.34
Cegedim (FRA:C7E) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Cegedim's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
10.96
/
32.14
=
0.34
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cegedim Median PS Value Related Terms
Cegedim Median PS Value Historical Data
* Premium members only.
The historical data trend for Cegedim's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:C7E vs VEEV, BTSG, TEM: Median PS Value Comparison
For the Health Information Services subindustry, Cegedim's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cegedim Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cegedim's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Cegedim's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.7256.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cegedim's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €44.293.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cegedim (FRA:C7E) has a Median PS Value of €32.14 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cegedim and its competitors. This is 3726% above median its historical median of 0.84. Over the past decade, Cegedim's Median PS Value has ranged from 0.34 to 1.60. According to the industry distribution chart, Cegedim ranks #38 out of 264 companies in the Healthcare Providers & Services industry, placing it in the top 14.4%.
Is Cegedim's Median PS Value too high?
Cegedim's current Median PS Value of €32.14 is 3726% above median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 1.60. Based on the distribution chart, Cegedim ranks #38 out of 264 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cegedim has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cegedim's Median PS Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cegedim ranks #38 out of 264 companies for Median PS Value. This places Cegedim in the top 14% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.70. Historically, Cegedim's own Median PS Value has ranged from 0.34 to 1.60 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.70, based on 264 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cegedim and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cegedim's current Median PS Value is €32.14, which is 3726% above median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cegedim stock overvalued right now?
Based on GuruFocus' analysis, Cegedim (FRA:C7E) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.57, compared to a current price of €10.96 — trading 12.8% below its estimated fair value. The current Median PS Value is €32.14, which is 3726% above median its 10-year median of 0.84. Cegedim's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Cegedim (FRA:C7E), the current Median PS Value is €32.14 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cegedim (FRA:C7E) Overvalued in 2026?
Based on GuruFocus' analysis, Cegedim stock appears to be undervalued.
The current stock price of €10.96 is trading 12.8% below its estimated GF Value™ of €12.57.
GuruFocus considers Cegedim to be Modestly Undervalued.
Key valuation signals for FRA:C7E:
Median PS Value: €32.14 (3726% above median its 10-year median of 0.84)
GF Value™: €12.57 vs. price of €10.96 (12.8% below fair value)
No single metric tells the full story. See the FRA:C7E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cegedim SA is a technology and services company offering digital flows of the healthcare ecosystem and B2B marketing, design of enterprise software for healthcare and insurance professionals. It is also engaged in human resources management and digitization. The company has two operating segments namely, Health insurance, HR and e-services; and Healthcare Professionals. Cegedim generates most of its revenue from France. The company's services include insurers solutions, promotional information, sales statistics of pharmaceutical products and digital promotion for healthcare companies.
81GF Score
Get the complete analysis for FRA:C7E
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:C7E has been successfully added to your 
